Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 2
2014 1
2016 3
2017 5
2018 13
2019 12
2020 13
2021 8
2022 11
2023 21
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Lodenafil.
Alshehri YM, Al-Majed AA, Attwa MW, Bakheit AH. Alshehri YM, et al. Among authors: attwa mw. Profiles Drug Subst Excip Relat Methodol. 2022;47:113-147. doi: 10.1016/bs.podrm.2021.10.004. Epub 2021 Dec 7. Profiles Drug Subst Excip Relat Methodol. 2022. PMID: 35396013 Review.
Vandetanib.
Al-Ghusn AI, Bakheit AH, Attwa MW, AlRabiah H. Al-Ghusn AI, et al. Among authors: attwa mw. Profiles Drug Subst Excip Relat Methodol. 2023;48:109-134. doi: 10.1016/bs.podrm.2022.11.004. Epub 2023 Feb 2. Profiles Drug Subst Excip Relat Methodol. 2023. PMID: 37061272 Review.
Editorial: Drug metabolism-induced organ toxicity.
Kadi AA, Li Y, Parashar A, Attwa MW. Kadi AA, et al. Among authors: attwa mw. Front Pharmacol. 2024 Jan 25;15:1362229. doi: 10.3389/fphar.2024.1362229. eCollection 2024. Front Pharmacol. 2024. PMID: 38333014 Free PMC article. No abstract available.
Ponatinib: A comprehensive drug profile.
Attwa MW, Alkahtani HM, El-Azab AS, Abdel-Aziz AA, Abdelhameed AS, Kadi AA, Hassan SB, Zeidan DW, Bakheit AH. Attwa MW, et al. Profiles Drug Subst Excip Relat Methodol. 2024;49:81-114. doi: 10.1016/bs.podrm.2023.11.005. Epub 2024 Jan 25. Profiles Drug Subst Excip Relat Methodol. 2024. PMID: 38423710 Review.
Avanafil: A comprehensive drug profile.
Al-Majed AA, AlKhairallah A, Attwa MW, Alkahtani HM, El-Azab AS, Abdel-Aziz AA, Alkhider A, Hassan SB, Bakheit AH. Al-Majed AA, et al. Among authors: attwa mw. Profiles Drug Subst Excip Relat Methodol. 2024;49:115-151. doi: 10.1016/bs.podrm.2023.11.006. Epub 2023 Dec 13. Profiles Drug Subst Excip Relat Methodol. 2024. PMID: 38423706 Review.
Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy.
Al-Dhfyan A, Alaiya A, Al-Mohanna F, Attwa MW, AlAsmari AF, Bakheet SA, Korashy HM. Al-Dhfyan A, et al. Among authors: attwa mw. J Adv Res. 2023 Aug;50:177-192. doi: 10.1016/j.jare.2022.10.006. Epub 2022 Oct 26. J Adv Res. 2023. PMID: 36307019 Free PMC article.
85 results